You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ROR1

Showing 1 - 25 of 82
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

Terminated
Has Results
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +12 more
  • Laboratory Biomarker Analysis
  • ROR1 CAR-specific Autologous T-Lymphocytes
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 11, 2022

Breast Tumors Trial in La Jolla (Cirmtuzumab + Paclitaxel)

Active, not recruiting
  • Breast Neoplasms
  • Cirmtuzumab + Paclitaxel
  • La Jolla, California
    University of California, San Diego
May 16, 2022

Advanced Solid Tumor, Advanced Cancer, Triple Negative Breast Cancer Trial in Nashville, Houston, San Antonio (NBE-002)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Nashville, Tennessee
  • +2 more
Mar 3, 2022

Advanced/Metastatic Solid Tumors Trial in Frankston, Nedlands, Beijing (EMB07)

Not yet recruiting
  • Advanced/Metastatic Solid Tumors
  • Frankston, Victoria, Australia
  • +2 more
Nov 3, 2022

Lymphoma, Mantle-Cell, Lymphoma, Lymphoproliferative Disorders Trial (Zilovertamab, Ibrutinib, Placebo)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • +7 more
  • (no location specified)
Jun 21, 2022

Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)

Recruiting
  • Triple Negative Breast Cancer
  • +14 more
  • LYL797
  • Scottsdale, Arizona
  • +10 more
Jan 30, 2023

Advanced Solid Tumor, Advanced Lymphoma Trial in Australia, United States (CS5001)

Recruiting
  • Advanced Solid Tumor
  • Advanced Lymphoma
  • East Setauket, New York
  • +9 more
Jan 17, 2023

Liver Cancer, Lung Cancer, Breast Cancer Trial in Guangzhou (TILs and CAR-TILs targeting HER2, Mesothelin, PSCA, MUC1, Lewis-Y,

Recruiting
  • Liver Cancer
  • +7 more
  • TILs and CAR-TILs targeting HER2, Mesothelin, PSCA, MUC1, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2/6, ROR1, GD1, or B7-H3
  • Guangzhou, China
    Second Affiliated Hospital of Guangzhou Medical University
Apr 9, 2021

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (Cirmtuzumab (2-16

Recruiting
  • B-cell Chronic Lymphocytic Leukemia
  • +3 more
  • Cirmtuzumab (2-16 kg/mg) plus Ibrutinib
  • +5 more
  • Duarte, California
  • +12 more
Jun 16, 2022

Chronic Lymphocytic Leukemia Trial in La Jolla (cirmtuzumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
    UCSD Moores Cancer Center
Jul 29, 2020

Solid Tumor Trial in Kunming (RD14-01)

Recruiting
  • Solid Tumor
  • RD14-01
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Feb 18, 2023

Solid Tumor Trial (RD14-01 Cell injection)

Not yet recruiting
  • Solid Tumor
  • RD14-01 Cell injection
  • (no location specified)
Nov 28, 2022

Metastatic Castration-resistant Prostate Cancer Trial in La Jolla (Cirmtuzumab)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • La Jolla, California
    University of California San Diego
May 22, 2022

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 12, 2023

Triple Negative Breast Cancer, Nonsmall Cell Lung Cancer Trial in Rocky Mount

Recruiting
  • Triple Negative Breast Cancer
  • Nonsmall Cell Lung Cancer
    • Rocky Mount, North Carolina
      Accellacare of Rocky Mount -Dr. Bondy
    May 26, 2023

    Relapsed/Refractory Aggressive B-Cell Malignancies Trial (ONCT-808, Bridging Therapy)

    Not yet recruiting
    • Relapsed/Refractory Aggressive B-Cell Malignancies
    • ONCT-808
    • Bridging Therapy
    • (no location specified)
    Jan 19, 2023

    Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in London (NVG-111, NVG-111 (RP2D))

    Recruiting
    • Chronic Lymphocytic Leukaemia
    • +2 more
    • London, United Kingdom
      University College London Hospital
    Jun 22, 2021

    Language Development, Behavior, Child, Parenting Trial in New Brunswick (Usual care including ROR, Text messages, Connection to

    Recruiting
    • Language Development
    • +3 more
    • Usual care including ROR
    • +2 more
    • New Brunswick, New Jersey
      Rutgers Robert Wood Johnson Medical School
    Jan 12, 2023

    Breast Cancer Stage II Trial in France, Portugal, Spain (Ribociclib (neoadjuvant), Chemotherapy (adjuvant), Ribociclib

    Recruiting
    • Breast Cancer Stage II
    • Ribociclib (neoadjuvant)
    • +2 more
    • Avignon, France
    • +49 more
    Jul 7, 2022

    Chronic Lymphocytic Leukemia Trial in San Diego (Cirmtuzumab, Venetoclax)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • San Diego, California
      UCSD Koman Family Outpatient Pavilion
    Nov 24, 2021

    Cardiovascular Diseases Trial in Detroit (TruGenome Cardiovascular Disease test)

    Recruiting
    • Cardiovascular Diseases
    • TruGenome Cardiovascular Disease test
    • Detroit, Michigan
      Henry Ford Health System
    Jan 10, 2023

    Literacy, Parent-Child Relations, Language Development Trial in Cincinnati (Reading Bees app and children's book to enhance

    Recruiting
    • Literacy
    • +2 more
    • Reading Bees app and children's book to enhance parent-infant reading quality (0-2 month visit)
    • Reading Bees app and children's book to encourage alternatives to digital media (6-month visit)
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Aug 17, 2022

    School Readiness, Racial Socialization, Child Development Trial in Los Angeles (Cultural Pride Reinforcement for Early School

    Completed
    • School Readiness
    • +2 more
    • Cultural Pride Reinforcement for Early School Readiness (CPR4ESR)
    • Reach Out and Read (ROR)
    • Los Angeles, California
      Children's Hospital Los Angeles
    Nov 18, 2021

    Neoadjuvant Operable Breast Cancer Trial in Paris, Villejuif (Fluorouracile, Epirubicin, Cyclophosphamide)

    Completed
    • Neoadjuvant Operable Breast Cancer
    • Paris, France
    • +1 more
    Mar 14, 2022

    Renal Cell Carcinoma Trial in Shanghai (CCT301-38, CCT301-59)

    Active, not recruiting
    • Renal Cell Carcinoma
    • CCT301-38
    • CCT301-59
    • Shanghai, Shanghai, China
      Shanghai Public Health Clinical Center
    Oct 19, 2021